APPRAISAL Trial: A phase IIa study to evaluate the safety and preliminary efficacy of RESTEN-MP [AVI 4126] when used in conjunction with a bare metal stent in de novo native coronary artery lesions

Trial Profile

APPRAISAL Trial: A phase IIa study to evaluate the safety and preliminary efficacy of RESTEN-MP [AVI 4126] when used in conjunction with a bare metal stent in de novo native coronary artery lesions

Completed
Phase of Trial: Phase II

Latest Information Update: 02 Feb 2017

At a glance

  • Drugs AVI 4126 (Primary)
  • Indications Coronary artery disease; Coronary artery restenosis
  • Focus Therapeutic Use
  • Acronyms APPRAISAL
  • Sponsors Sarepta Therapeutics
  • Most Recent Events

    • 23 Aug 2007 Status changed from in progress to completed.
    • 11 Jul 2007 Six-month follow-up data has been reported.
    • 10 Jul 2007 Status changed from recruiting to in progress.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top